Welcome Guest | Register / Login

Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Nutra Pharma Corp - Key Facts 6
Nutra Pharma Corp - Key Employees 7
Nutra Pharma Corp - Key Employee Biographies 8
Nutra Pharma Corp - Major Products and Services 9
Nutra Pharma Corp - History 10
Nutra Pharma Corp - Company Statement 14
Nutra Pharma Corp - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 - Company Analysis 16
Company Overview 16
Nutra Pharma Corp - Business Description 16
Product Category: Luxury Feet 16
Overview 16
Product Category: Nyloxin 16
Overview 16
Performance 16
Product Category: Pet Pain-Away 16
Overview 16
Performance 17
R&D Overview 17
Nutra Pharma Corp - Corporate Strategy 18
Nutra Pharma Corp - SWOT Analysis 19
SWOT Analysis - Overview 19
Nutra Pharma Corp - Strengths 19
Nutra Pharma Corp - Weaknesses 20
Nutra Pharma Corp - Opportunities 21
Nutra Pharma Corp - Threats 22
Nutra Pharma Corp - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 - Company's Lifesciences Financial Deals and Alliances 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Nutra Pharma Corp, Recent Deals Summary 32
Section 5 - Company's Recent Developments 33
Mar 08, 2018: Nutra Pharma Announces Corporate Updates 33
Feb 21, 2018: Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures 34
Jan 25, 2018: Nutra Pharma Unveils Updated Websites 35
Jun 21, 2017: Nutra Pharma Announcing Launch of Luxury Feet 36
May 23, 2017: Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures 37
Section 6 - Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Nutra Pharma Corp, Key Facts 6
Nutra Pharma Corp, Key Employees 7
Nutra Pharma Corp, Key Employee Biographies 8
Nutra Pharma Corp, Major Products and Services 9
Nutra Pharma Corp, History 10
Nutra Pharma Corp, Subsidiaries 15
Nutra Pharma Corp, Key Competitors 23
Nutra Pharma Corp, Ratios based on current share price 24
Nutra Pharma Corp, Annual Ratios 25
Nutra Pharma Corp, Annual Ratios (Cont...1) 26
Nutra Pharma Corp, Interim Ratios 28
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Nutra Pharma Corp, Recent Deals Summary 32
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List of Figures
Nutra Pharma Corp, Performance Chart (2013 - 2017) 27
Nutra Pharma Corp, Ratio Charts 29
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Nutra Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy